New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Xenetic Biosciences, Inc.
XBIO
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

6M

Biotechnology

Next Earning date - 08 Nov 2024

6M

Biotechnology

Next Earning date - 08 Nov 2024

3.82USD
Shape0.18 ( 4.94%)
favorite-chart

Relative Strenght

53
favorite-chart

Volume Buzz

-75%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

27%

Quote Panel

Shape
Updated October 20, 2024
1W 2.96 % 1M -1.04 % 3M -9.91 % 1Y 10.72 %

Key Metrics

Shape
  • Market Cap

    5.89M


  • Shares Outstanding

    1.54M


  • Share in Float

    1.25M


  • Dividende

    0


  • Earning Date

    08 Nov 2024


  • Price Target

    3.8199


  • Average Volume

    17139


  • Beta

    2.258


  • Range

    2.78-5.2


  • Industry

    Biotechnology


  • Website

    https://www.xeneticbio.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

2.34x

P/S Ratio

0.79x

P/B Ratio

0.0

Debt/Equity

-186.3%

Net Margin

$-3.1

EPS

How XBIO compares to sector?

P/E Ratio

Relative Strength

Shape

XBIO

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$2M

Shape148%

2025-Revenue

$0.66

Shape20%

2025-EPS

$1M

Shape19%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.60
vs -1.30

Q4.22

arrow
arrow

N/A

-1.00
vs -0.18

Q1.23

arrow
arrow

N/A

-0.60
vs -1.20

Q2.23

arrow
arrow

N/A

-0.69
vs -1.90

Q3.23

arrow
arrow

N/A

-0.69
vs -0.60

Q4.23

arrow
arrow

N/A

-0.77
vs -1.00

Q1.24

arrow
arrow

N/A

-0.78
vs -0.60

Q2.24

arrow
arrow

N/A

-0.83
vs -0.69

Q3.24

arrow
arrow

N/A

-0.14
vs -0.69

Q4.24

arrow
arrow

N/A

-0.20
vs -0.77

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+19%

414.3K  vs 349.3K

Q4.22

arrow
arrow

+46%

487K  vs 332.6K

Q1.23

arrow
arrow

+56%

605.8K  vs 389K

Q2.23

arrow
arrow

+56%

651K  vs 416.7K

Q3.23

arrow
arrow

+48%

611.2K  vs 414.3K

Q4.23

arrow
arrow

+38%

672K  vs 487K

Q1.24

arrow
arrow

-16%

510.8K  vs 605.8K

Q2.24

arrow
arrow

+12%

726.4K  vs 651K

Q3.24

arrow
arrow

+23%

750K  vs 611.2K

Q4.24

arrow
arrow

-66%

230K  vs 672K

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-5%

-0.05
vs -0.17

Q4.22

arrow
arrow

-10%

-0.10
vs -0.05

Q1.23

arrow
arrow

-6%

-0.06
vs -0.10

Q2.23

arrow
arrow

-9%

-0.09
vs -0.06

Q3.23

arrow
arrow

-10%

-0.10
vs -0.09

Q4.23

arrow
arrow

-12%

-0.12
vs -0.10

Q1.24

arrow
arrow

-14%

-0.14
vs -0.12

Q2.24

arrow
arrow

-17%

-0.17
vs -0.14

Institutionnal OwnershipShape

status-upQoQ

Q2.21

arrow
arrow

11

11
vs 10

10%

Q3.21

arrow
arrow

16

16
vs 11

45%

Q4.21

arrow
arrow

20

20
vs 16

25%

Q1.22

arrow
arrow

13

13
vs 20

-35%

Q2.22

arrow
arrow

12

12
vs 13

-8%

Q3.22

arrow
arrow

13

13
vs 12

8%

Q4.22

arrow
arrow

18

18
vs 13

38%

Q1.23

arrow
arrow

18

18
vs 18

NA

Earnings Growth

Latest News